BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 1998
View Archived Issues
Cambridge NeuroScience: Q3 1998 highlights
Read More
Pharming: Q3 and nine-month highlights
Read More
Centocor: clinical development program update
Read More
Vertex reports preliminary data on Incel in soft tissue carcinoma and initiates new phase II trial
Read More
Abbott obtains license to market Nyotran
Read More
New U.S. patent provides protection for improved Avicine formulations
Read More
Intellivax presents promising phase I data for intranasal vaccine for shigellosis
Read More
DBO-83: novel nicotinic agonist with antiamnestic activity
Read More
Zeneca files sNDA for Accolate asthma therapy
Read More
Antihyperalgesic effects of SB-235863 presented at Society for Neuroscience meeting
Read More
Nortran enters collaborative agreement with Astra
Read More
New warnings issued for Tasmar; E.U. suspends use
Read More
Picornavirus protease inhibitors from Agouron especially useful for rhinovirus infections
Read More
Clarion prepares novel compounds for cancer, psoriasis and inflammation
Read More
Erythromycin derivatives with high activity against sensitive and resistant microorganisms
Read More
Antitumor tetramic acid compound produced by Streptomyces
Read More
Dual NK1 and NK2 receptor antagonists under study at Sankyo for respiratory disorders, incontinence
Read More
Ligand reports design of new nonsteroidal human progesterone agonists
Read More
Discovery of potent, nontoxic, orally active ACAT inhibitors reported by Fujisawa
Read More
Parke-Davis identifies potent inhibitor of PDGF receptor TK and PDGF-dependent tumor growth
Read More
New oral HRT option approved by FDA
Read More
SangCya launched in U.S. less than three weeks following approval
Read More
Latanoprost monotherapy is as effective as combination therapy in lowering IOP
Read More
Imutec changes name to Lorus Therapeutics; achievements highlighted
Read More
Thalidomide analogue CC-1069 shows potent antiarthritic activity in rat model
Read More
Gastrimmune enters phase III trials for pancreatic cancer
Read More
Celgene describes SelCID compounds for treatment of CHF
Read More
Meridian completes Gull Laboratories acquisition
Read More
Neuroprotective effects and mode of action of Ono-2506 detailed at recent meeting
Read More